SOLX's Unattributed VC - II Round

SOLX raised a round of funding on January 20, 2012. Investors include MVM Life Science Partners.

SOLX has developed a surgical laser and method of treatment for glaucoma, the second most common cause of blindness in the elderly. SOLX's DeepLight Glaucoma Treatment System is being developed to pro…

Articles about SOLX's Unattributed VC - II Round: